Showing results (301-310 of 474) with videos related to

Sort By:
Pageof 48
Clinical and Translational Gastroenterology|May 31, 2023
IL-6-Dependent STAT3 Activation and Induction of Proinflammatory Cytokines in Primary Sclerosing CholangitisLeona Dold, Leonie Frank, Philipp Lutz, et al.
The Journal of Biological Chemistry|April 20, 2010
Generation of a family-specific phage library of llama single chain antibody fragments that neutralize HIV-1Willie W L Koh, Soren Steffensen, Maria Gonzalez-Pajuelo, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2025
CIT tumor lines: A novel series of immunogenic squamous cell skin carcinoma cell lines derived from chemical carcinogenesisMiho Tanaka, Robert Letchworth, Alina A Barnes, et al.
Studies in Health Technology and Informatics|May 23, 2026
FEDERA Salud: Early Adoption of SIMPL for Federated Health Data Spaces in SpainPaloma Bravo-Del-Cid, Francisco Rey-Garduño, Maria Gonzalez-Lopez, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|August 8, 2019
Endogenous stimulation is responsible for the high frequency of IL-17A-producing neutrophils in patients with rheumatoid arthritisMaria Gonzalez-Orozco, Rosa E Barbosa-Cobos, Paola Santana-Sanchez, et al.
Annals of Surgical Oncology|September 28, 2011
Triple-negative breast cancer is not a contraindication for breast conservationFarrell C Adkins, Ana Maria Gonzalez-Angulo, Xiudong Lei, et al.
Global Mental Health (Cambridge, England)|November 26, 2025
Evaluating "Conmigo, Contigo, Con Todo": Effects of a community mental health initiative on Afro-Colombian teachersLina Maria Gonzalez-Ballesteros, Oscar Eduardo Gómez Cárdenas, Camila Andrea Castellanos Roncancio, et al.
Breast Cancer Research and Treatment|March 23, 2010
Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survivalWendy A Woodward, Pauline T Truong, Tse-Kuan Yu, et al.
The Lancet. Oncology|April 1, 2018
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 studyGeorgina V Long, Victoria Atkinson, Serigne Lo, et al.
Oncotarget|July 23, 2016
Fatal gastrointestinal toxicity with ipilimumab after BRAF/MEK inhibitor combination in a melanoma patient achieving pathological complete responseMaria Gonzalez-Cao, Aram Boada, Cristina Teixidó, et al.
Pageof 48